Literature DB >> 12458064

Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.

Wolfgang Schreiber1, Harald Herkner, Maria Koreny, Andreas Bur, Michael M Hirschl, Dietmar Glogar, Kurt Huber, Anton N Laggner.   

Abstract

BACKGROUND: Several predictors of survival have been described in selected subgroups of patients suffering from acute myocardial infarction. However, data on unselected patients with acute myocardial infarction and cardiogenic shock, including patients with out-of hospital cardiac arrest, are missing. We aimed to assess predictors of survival for an unselected cohort of patients representative of clinical practice who experienced acute myocardial infarction and required continuous catecholamine support for circulatory failure.
METHODS: The study was performed at a 2000 bed university hospital. All consecutive patients admitted to our emergency department with acute myocardial infarction were prospectively enrolled in a clinical trial from 1993 to 2000.
DESIGN: A retrospective cohort study was performed on patients with myocardial infarction requiring catecholamine support within the first 24 h. Primary endpoint was in-hospital mortality.
RESULTS: The analysis was carried out on 262 patients, 189 men (72%), median age 65 years (IQR 53-73). Out-of-hospital cardiac arrest was reported in 47% (122/262). In-hospital mortality was 53% (138/262). Survivors as compared to non-survivors exhibited significant differences with respect to age (60 vs. 68 years, P<0.0001), systolic and diastolic blood pressure on admission (110 vs. 102 mmHg, P=0.01 and 64 vs. 58 mmHg, P=0.006, respectively), initial blood serum lactate (6.8 vs. 8.3, P=0.01), peak CKMB level (93 vs. 138 U/l, P=0.005), use of adrenaline (epinephrine) (38 vs. 68%, P<0.0001) and any attempt of revascularisation (76 vs. 63%, P=0.03). In a multivariate model younger age [OR 1.06 (CI 1.03-1.10), P<0.001], no use of adrenaline [OR 2.63 (CI 1.35-5.26) P=0.005] and lower peak CKMB [OR 1.01 (CI 1.01-1.01), P<0.0001] were independently associated with in-hospital survival.
CONCLUSION: In unselected patients including CPR survivors with acute myocardial infarction requiring continuous catecholamine support, younger age, the absence of continuous adrenaline administration and a lower peak CKMB were independently associated with increased in-hospital survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458064     DOI: 10.1016/s0300-9572(02)00266-6

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  4 in total

1.  Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.

Authors:  Valentine Léopold; Etienne Gayat; Romain Pirracchio; Jindrich Spinar; Jiri Parenica; Tuukka Tarvasmäki; Johan Lassus; Veli-Pekka Harjola; Sébastien Champion; Faiez Zannad; Serafina Valente; Philip Urban; Horng-Ruey Chua; Rinaldo Bellomo; Batric Popovic; Dagmar M Ouweneel; José P S Henriques; Gregor Simonis; Bruno Lévy; Antoine Kimmoun; Philippe Gaudard; Mir Babar Basir; Andrej Markota; Christoph Adler; Hannes Reuter; Alexandre Mebazaa; Tahar Chouihed
Journal:  Intensive Care Med       Date:  2018-06-01       Impact factor: 17.440

Review 2. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

3.  Isoflurane Sedation in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation Treatment for Cardiogenic Shock-An Observational Propensity-Matched Study.

Authors:  Clemens Scherer; Danny Kupka; Thomas J Stocker; Dominik Joskowiak; Hanna Scheuplein; Carmen Maria Schönegger; Frank Born; Christopher Stremmel; Enzo Lüsebrink; Konstantin Stark; Mathias Orban; Tobias Petzold; Sven Peterss; Jörg Hausleiter; Christian Hagl; Steffen Massberg; Martin Orban
Journal:  Crit Care Explor       Date:  2020-03-24

4.  Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock.

Authors:  Nanna Louise Junker Udesen; Ole Kristian Lerche Helgestad; Jakob Josiassen; Christian Hassager; Henrik Frederiksen Højgaard; Louise Linde; Jesper Kjaergaard; Lene Holmvang; Lisette Okkels Jensen; Henrik Schmidt; Hanne Berg Ravn; Jacob Eifer Møller
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.